Objective: This study aimed to assess the prevalence of cervical High-Grade Squamous Intraepithelial Lesions (HSIL) in women outside the screening age recommended by the Brazilian Guidelines for ...

Cervical cancer is a leading health threat for women worldwide, ranking fourth in prevalence, with 660,000 new diagnoses and 350,000 fatalities recorded in 2022, according to the World Health ...

This study reports important new insights into the roles of a long noncoding RNA, lnc-FANCI-2, in the progression of cervical cancer induced by a type of human papillomavirus. Through a blend of cell ...

Version of Record: This is the final version of the article. The authors attempted to dissect the function of a long non-coding RNA, lnc-FANCI-2, in cervical cancer. They profiled lnc-FANCI-2 in ...

Human papillomavirus (HPV) is the most common sexually transmitted infection. About 90% of HPV infections are transient, resolving without any need for intervention. Most of HPV infections are ...

Please provide your email address to receive an email when new articles are posted on . Only 45.5% of women treated for high-grade cervical dysplasia completed two surveillance co-tests within 30 ...

Incidence of preliminary cervical cancer decreased by approximately 80% among women aged 20-24 years in the United States since the widespread use of the human papillomavirus (HPV) vaccine, according ...

Among women ages 20-24 who were screened from 2008-2022, cervical precancer rates decreased by about 80%. Among women ages 25-29, CIN3+ rates decreased by 37%. These data support vaccinating children ...

Two symptoms prompted Jenna Anne Johnson, 21, to undergo a routine pap smear last summer. That test revealed she had Stage 3 cervical cancer that later progressed to Stage 4. Instagram / Jenna Anne ...

ST. LOUIS – There is a new option available for cervical cancer screening for women 30 years of age. The U.S. Health Preventative Services Task Force has endorsed self-testing to help reduce cancer ...